Ideal candidates for SIRT therapy in Turkey include patients with intermediate-stage primary liver cancer or colorectal metastases that are unresectable. Suitable patients must demonstrate preserved liver function, typically Child-Pugh class A or B, and a good performance status. This interventional radiology procedure leverages Y-90 microspheres to target tumors directly.
- Tumor type: Primary hepatocellular carcinoma or liver-dominant metastatic disease from colorectal or neuroendocrine origins.
- Liver function: Requires Child-Pugh A or B scores to ensure the liver tolerates radiation.
- Performance status: Patients should have an ECOG score of 0 to 1 for optimal recovery.
- Disease extent: Best results occur when cancer is confined to the liver without extensive spread.
Bookimed Expert Insight: While SIRT is often a last resort, high-volume centers like Anadolu Medical Center use it as a bridge to transplant. Their affiliation with Johns Hopkins ensures protocols mirror US standards. Patients with unilateral portal vein thrombosis are still candidates here, whereas many smaller clinics may decline these complex cases.
Patient Consensus: Patients emphasize that a full PET-CT workup in Turkey is vital before starting. Many report that younger, fitter individuals under 70 tend to recover significantly faster after the microsphere injection.